Literature DB >> 9466637

Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes.

A L Avins1, W S Browner.   

Abstract

CONTEXT: A patient's coronary heart disease (CHD) risk must be correctly classified to successfully apply risk-based guidelines for treatment of hypercholesterolemia.
OBJECTIVE: To determine the classification accuracy of the National Cholesterol Education Program (NCEP) CHD risk-stratification system and compare it with a simple revised system that gives greater weight to age as a CHD risk factor.
DESIGN: Modeling of 10-year CHD risk, using equations from the Framingham Heart Study applied to a cross-sectional survey of the US population.
SUBJECTS: The 3284 subjects aged 20 to 74 years surveyed in the Second National Health and Nutrition Examination Survey (1978-1982) who had fasting lipid levels measured. MAIN OUTCOME MEASURES: The area under the receiver operating characteristic curve (AUC) for 10-year CHD risk for the NCEP and revised scales.
RESULTS: Among all adults with a low-density lipoprotein cholesterol value of at least 4.1 mmol/L (160 mg/dL), the NCEP system showed fairly good discrimination (AUC=0.90), though there was a substantial decline among men 35 to 74 years old and women 55 to 74 years old (AUC=0.81). By contrast, the revised system showed superior performance in all hypercholesterolemic adults (AUC=0.94-0.97) as well as in the subgroup of men 35 to 74 years old and women 55 to 74 years old (AUC=0.94-0.96).
CONCLUSIONS: Simple modifications of the NCEP treatment criteria result in a substantially improved ability to discriminate between higher and lower CHD risk groups. Unlike the NCEP system, this revised system retains its classification ability in all age groups studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466637     DOI: 10.1001/jama.279.6.445

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Statins: underused by those who would benefit.

Authors:  S B Hulley; D Grady; W S Browner
Journal:  BMJ       Date:  2000-10-21

2.  The relative merits of population-based and targeted prevention strategies.

Authors:  Donna M Zulman; Sandeep Vijan; Gilbert S Omenn; Rodney A Hayward
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

3.  Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Bo Ding; Brendan T Keenan; Katherine Liao; Karen H Costenbader; Lars Klareskog; Lars Alfredsson; Lori B Chibnik
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-07       Impact factor: 4.794

4.  Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis.

Authors:  Rodney A Hayward; David M Kent; Sandeep Vijan; Timothy P Hofer
Journal:  BMC Med Res Methodol       Date:  2006-04-13       Impact factor: 4.615

5.  An Examination of the Relationship between Lipid Levels and Associated Genetic Markers across Racial/Ethnic Populations in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Lucia Johnson; Jonathan Zhu; Erick R Scott; Nathan E Wineinger
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.